Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

B of A Securities Analyst Initiates Coverage on Merit Medical Systems with Neutral Rating and 87 Price Target

Elaine Mendonca by Elaine Mendonca
February 7, 2024
in Breaking News
0
Navigating Legal Battles: A Deep Dive into High-Stakes Cryptocurrency Disputes
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

On February 7, 2024, Craig Bijou, an analyst at B of A Securities, has started covering Merit Medical Systems (NASDAQ:MMSI) and has given it a Neutral rating. He has also revealed a Price Target of $87 for the stock. This signifies that the analyst holds a balanced viewpoint, neither too optimistic nor pessimistic, regarding the stock’s future performance. The $87 Price Target serves as a benchmark, indicating the analyst’s belief that the stock is fairly valued at this level. This valuable information offers valuable insights to investors and market participants who are closely monitoring Merit Medical Systems’ stock.

MMSI Stock Shows Steady Performance and Potential for Growth in 2024

On February 7, 2024, MMSI stock showed a steady performance, trading in the middle of its 52-week range and above its 200-day simple moving average. The stock closed at $78.62, representing a slight increase of $0.26 or 0.33% since the market last closed.

MMSI’s position in the middle of its 52-week range suggests stability and consistency in its performance.

Trading above its 200-day moving average indicates a long-term upward trend for MMSI.

The modest price increase on February 7, 2024, shows positive movement in the stock’s value.

The lack of significant price changes in after-hours trading suggests no major news or events impacting the stock’s performance.

Overall, MMSI stock demonstrated stability, potential for growth, and may be an attractive option for investors.

Stable Performance and Impressive Financial Results: MMSI Stock Analysis for February 7, 2024

MMSI stock demonstrated a stable performance on February 7, 2024, reflecting the company’s consistent revenue growth and increasing net income. MMSI’s total revenue for the past year amounted to $1.15 billion, showing a 6.21% increase compared to the previous year. The company’s net income also witnessed significant growth over the past year, with a net income of $74.52 million, reflecting a remarkable 53.79% increase compared to the previous year. MMSI’s EPS for the past year stood at $1.29, indicating a substantial increase of 52.95% compared to the previous year. Overall, MMSI’s stock performance on February 7, 2024, was positive, reflecting the company’s impressive financial results. Investors and analysts are likely to view MMSI as a promising investment opportunity, considering its consistent revenue growth, increasing net income, and rising earnings per share. However, further research and analysis are recommended before making any investment decisions.

Tags: MMSI
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Investing

Jefferies Analyst Initiates Coverage on ZoomInfo Technologies with a Buy Rating and 20 Price Target

Finance_Investment (5)

Financial Analysts Express Optimism for Civitas Resources Stock Performance

Energy Company Markets and money

RBio Energy Corporations Transformative Journey Becoming a Publicly Traded Company

Recommended

Gold Stock

Gold Nears Historic Peak as Market Anticipation Builds

2 months ago
Dentist

Advancements in Oral Healthcare: The Business Impact of Highly Trained Surgeons

2 years ago
Archer Aviation Stock

Archer Aviation Strengthens Market Position Through Strategic Patent Acquisition

4 months ago
SNDR stock news

Yousif Capital Management LLC Reduces Stake in Steven Madden, Ltd.: Implications for the Company’s Future Performance

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Graftech Shares Plunge on Bleak Quarterly Results

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

Conduent Faces Mounting Fallout from Major Data Breach Ahead of Earnings

Blue Ridge Bankshares Emerges from Regulatory Challenges with Return to Profitability

Navigating the Interest Rate Tightrope: Bank7’s Path Forward

Trending

Design Therapeutics Stock
Analysis

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

by Rodolfo Hanigan
February 7, 2026
0

Investor attention is turning to the upcoming catalysts for Design Therapeutics, a biotechnology firm advancing its GeneTAC...

Vigil Neuroscience Stock

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

February 7, 2026
Repay Holdings Stock

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

February 7, 2026
Graftech Stock

Graftech Shares Plunge on Bleak Quarterly Results

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Design Therapeutics Approaches Key Clinical Milestones with Ample Funding
  • Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy
  • Repay Holdings: Annual Report to Test Strategic Refinancing Success

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com